Produkty 1595275-71-0

CAS 1595275-71-0 występuje w naszej ofercie pod nazwami: SG3199, SG3199, 98.33%, SG3199 (Standard), SG3199, 94%, SG3199, 98.94%. Oferty producentów: GLPBio, Biosynth, MedChemExpress, Ambeed, Chemat. Dostępne opakowania: 1mg, 2mg, 5mg, 10 mg, 5 mg, 1 mg, 25 mg, Get quote.

SG3199
GLPBio, Biosynth
  • opakowanie: 1mg, 2mg, 5mg
  • Warianty: 4
od 3995,08
Zobacz produkt
SG3199, 98.33%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 1 mg, 25 mg
  • Warianty: 4
od 4197,43
Zobacz produkt
SG3199 (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
SG3199, 94%
Ambeed
  • opakowanie: 5mg, 10mg
  • Warianty: 2
od 6333,38
Zobacz produkt
SG3199, 98.94%
Chemat
  • opakowanie: 1mg
  • Warianty: 1
od 9054,80
Zobacz produkt
(11aS,11a'S)-8,8'-(Pentane-1,5-diylbis(oxy))bis(7-methoxy-2-methyl-1,11a-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one), 94%
BLDpharm
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
od 2502,48
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6aS)-3-[5-[[(6aS)-2-methoxy-8-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methyl-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-11-one (CAS 1595275-71-0) to związek chemiczny o wzorze sumarycznym C33H36N4O6 i masie molowej 584.7 g/mol. Nazwa systematyczna IUPAC: (6aS)-3-[5-[[(6aS)-2-methoxy-8-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methyl-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-11-one. InChIKey: YMTZZJOPSATRTO-GOTSBHOMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC33H36N4O6
Masa molowa584.7 g/mol
Nazwa IUPAC(6aS)-3-[5-[[(6aS)-2-methoxy-8-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methyl-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
InChIKeyYMTZZJOPSATRTO-GOTSBHOMSA-N
SMILESCC1=CN2[C@@H](C1)C=NC3=CC(=C(C=C3C2=O)OC)OCCCCCOC4=C(C=C5C(=C4)N=C[C@@H]6CC(=CN6C5=O)C)OC

Dane obliczone przez PubChem (NCBI)

Synonimy: orb1909128
Izomery (ten sam wzór sumaryczny)
3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
3-[2-[[3-(2-carboxyethyl)-5-[(E)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
3-[2-[[3-(2-carboxyethyl)-5-[(E)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
3-[2-[[6-(2-carboxyethyl)-7,11-dimethyl-12-oxo-4,13-diazatricyclo[8.3.0.03,7]trideca-1,3,5,9-tetraen-5-yl]methyl]-5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid C33H36N4O6
(6aS)-3-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one C33H36N4O6
N'-[5-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-6-oxo-1H-pyrimidin-2-yl]-N,N-dimethylmethanimidamide C33H36N4O6
N-[[(1R,3S,3aR,8bR)-3-(3-aminophenyl)-8b-hydroxy-8-methoxy-3a-(4-methoxyphenyl)-6-(1,3-oxazol-2-yl)-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-1-yl]methyl]-2-(dimethylamino)acetamide C33H36N4O6